Form 4: Dynavax Technologies Director Scott Dunseth Myers Reports Stock and Option Transactions

Director Scott Dunseth Myers reports acquisition of restricted stock units and stock options, along with disposal of common stock.

Summary

• On May 23, 2024, Scott Dunseth Myers, a director of Dynavax Technologies Corp, reported transactions involving the company's stock.
• Myers acquired 5,357 shares of common stock at $0 and disposed of 5,357 shares.
• Following these transactions, Myers beneficially owns 25,446 shares of common stock.
• Myers also acquired 22,500 stock options with an exercise price of $11.85, exercisable from May 22, 2031.
• These options vest one year from the grant date, contingent upon continued service to the company.
• Myers also holds 22,500 restricted stock units (RSUs), each representing a right to receive one share of DVAX Common Stock, vesting one year from the grant date with a mandatory deferral of release of RSU shares six months and one day after the Reporting Person no longer provides services to the Company.

Sentiment

Score: 6

Explanation: Neutral sentiment as the document is a standard regulatory filing detailing insider transactions. The acquisition of options and RSUs could be seen as a slightly positive sign, but it's a routine occurrence.

Positives

• The acquisition of stock options and restricted stock units by a director signals confidence in the company's future performance.

Future Outlook

The vesting of the stock options and RSUs is contingent upon the director's continued service to the company.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to monitor the actions of those with privileged information.

Stakeholder Impact

• The transactions provide shareholders with insight into the actions of a company director.

Key Dates